Survey Data Highlight Positive Attitudes About Telepsychiatry Among Providers
This study examined the experience and attitudes of mental health care providers towards telehealth.
Practice Management
Clinical Preventive Service Use Varies Across the United States
Researchers analyzed data to examine the prevalence of use of 10 recommended clinical preventive services among persons aged 18 years and older.
Predictors of Relapse in Patients With Chronic Hepatitis B Who Discontinue Nucleos(t)ide Analogue Therapy
Researchers analyzed data from patients with chronic hepatitis B to identify predictors of relapse in those who discontinued NAs and determined if existing rules for stopping NA therapy can be improved.
Predictors of Relapse in Patients With Chronic Hepatitis B Who Discontinue Nucleos(t)ide Analogue Therapy
Researchers analyzed data from patients with chronic hepatitis B to identify predictors of relapse in those who discontinued NAs and determined if existing rules for stopping NA therapy can be improved.
Early Diagnosis and Treatment of Blacks with HIV Are Especially Needed In Rural Settings
Study authors evaluated care outcomes among black persons diagnosed with HIV during 2018 in rural, urban, and metropolitan areas.
Flu Vaccine Rate Expected to Reach All-Time High for 2020-2021 Season
In December 2020, researchers conducted a survey of 1027 adults to determine percentage of those receiving, or intending to receive, influenza vaccination.
Immunocompromised Patients at Risk for Prolonged Infectiousness of SARS-CoV-2
Study authors studied respiratory samples and sera for SARS-CoV-2 in 3 deeply immunocompromised patients.
New Data Show Authorized Dose of Bamlanivimab-Etesevimab Cuts COVID-19 Hospitalizations, Death
The new cohort included 769 high-risk patients aged 12 years and older with mild to moderate COVID-19.
First OTC Molecular COVID-19 Test Gets EUA for At-Home Use
The test correctly identified 96% of positive samples from individuals known to have symptoms and 100% of positive samples from individuals without symptoms.
Real-World Data Demonstrate Effectiveness of Pfizer-BioNTech COVID-19 Vaccine
The analysis was conducted when more than 80% of tested specimens in Israel were variant B.1.1.7 (UK variant).
-
Loading...
-
Loading...
Next post in COVID19
